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The iron-binding prcpertios of melanotransferrin, the tumour-associated antigen also known as ~97, have been investigated by UWvisible and 
Ruorescencc spectroscopy, amino acid sequence comparison, and modelling. These show that, in contrast o other vansferrins. mclanotransferrin 
binds only one Fe’+ ion per molecule. The binding properties of its N-terminal site arc similar to other transrcrrins, but its C-terminal site does 
not bind iron at all. The differences ca:l be related to spe;i!ic amino acid changes in the C-terminal site. 
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I, INTRODUCTION 
Melanotransferrin, (MT& also known as the 
tumour-associated antigen, p97, is a monomeric glyco- 
protein, Ii/f, 97,000, which is expressed by human me- 
lanoma cells and certain other tissues [l-3], but is pres- 
ent only in trace amounts in normal adult tissues [4]. Its 
amino acid sequence [S] shows a high level of identity 
with proteins of the transferrin family (-40% identity 
with human transferrin or lactoferrin), it binds iron [6] 
and it has been proposed to play a role in iron trans- 
location [5]. 
MTf does, however, differ significantly from other 
transferrins. It is membrane-bound, and it differs in 
certain key amino acid residues which in other trans- 
ferrins are involved in iron binding. Examination of the 
MTf sequence in relation td the three-dimenqional 
structures of human lactoferrin [7,83 and rabbit serum 
transferrin [9] has Ied to the proposal that it has an 
intact ransferrin-type iron binding site in its N-terminal 
half but a possibly defective site in its C-terminal half 
[lo]. We have tested this proposal by investigation ofthe 
iron-binding properties of MTf, and discuss the results 
in the light of its presumed three-dimensional structure. 
2. MATERIALS AND METHODS 
2. I. isolation of MT/ 
MTf was purified from cell culture supcrnatanls of transfected 
mouse melanoma clone 2a cells [I l] by immunoafinity chromatogra- 
phy, A typical batch purification consisted of a 20 1 culture of cells 
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contained in ten IO-shelf cell factories. The cultures were allowed to 
incubate at 37°C for 10 days at which time the cells had grown to 
confluence and were showing signs of deterioration. Cell debris was 
removed by filtration and the filtrate was concentrated IO- to 1%fold 
with a Pellicon ultrafiltration system (Millipore) using a 5 sq. ft. 3O,ooO 
NMWL casctte. The retentate (approx. 2 I) was 0.2 pm filtered and 
applied overnight o a column (1.6 x 16 cm) of immobilize4 96.5 mAb 
[3] that had been previously washed with 0. I M citricacid. pH 2.2, and 
equilibrated in PBS, pH 7.2. The column was washed thoroughly with 
PBS and the bound MTf was cluted with 0.1 M citrate bulTer, pH 4.0, 
followed by immediate neutralization with Tris. The purified MTf 
(approx. IO mg) was dinlysed into PBS and sterile filtered. Batch 
analysis consisted of gel filtration HPLC, SDS-PAGE, isoelectric 
focusing and double-determinant binding ELISA, 
2.2. Mcamrawtrs of irott bittding 
Iron was added as ferric nitrilotriacetatc (FcNTA) to solutions of 
MTf in 0.025 M Tris-HCI, pH 7.8, containing 0.01 M NaHCO, and 
0. I M NaCI. The protein concentration was estimated using an cxlinc- 
tion coefficient at 280 nm. &g = 12.0 cm-‘, as determined by quantita- 
tive amino acid analysis. For iron titrations aliquots of FcNTA were 
added to iron-free MTf at a concentration of 1.2 mdml. Iron binding 
was monitored either by the increase r!f absorbance at 464 nm. in tic 
visible electronic spectrum, or from the quenching of fluorescence at
338 nm. For comparison similar titrations were perfo~~M for human 
lactofcrrin under the same conditions (using an exlinction coefficient, 
&$. of 10.9 cm-’ [12]). 
Electronic absorption spectra in the range 215&?&I nm were 
measured with a Hewlett-Packard HP8452A diode array spectropho- 
tometer. Fluorescence measurements were made with an Aminco SPF- 
500 spectrofluorimetcr, with excitation at 285 nm and emission a1 338 
nm. 
2.3. Meastrretncnrs of pH-mediated iron rekuse 
Iron-saturated MTf (2 m&ml) was diilysed against a series of buffer 
solutions in the pH range 8.0-3.0, at intervals of 0.5 pH unit. BulTcr 
solutions used were; pH 8.0-7.0, 0.05 M Tris-HCI; pH 6.5-6.0.0.05 
M MES; pH 5.5-3.&O. 1M sodium acetate; pH 3.0-2.0,O.l M glycine- 
HCI. All buffer solutions contained 0.2 M NaCI. At each pH, the MTf 
solution was dialysxl for 24 h after which its iron saturation was 
es~imaid from !hr ratio A&A, RralX Iil~flG?ilXXS 1bCC I;3& 
on human lactoferrin and humans erum transferrin under identical 
conditions. 
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Fig. I I Iron-binding titrations for mclanotransfxrin CO), compnrcd with human lactofcrrin (+). Plots of (a) the increase in absorbance at 464 nm 
and (b) fluorescence quenching, measured as % of initial fluorescence r maining, as a function of mole ratio (moles Fe” addc&moles protein). 
3. RESULTS 
The electronic absorption spectrum of fully iron- 
saturated MTf shows a peak at 464 nm, and a minimum 
at 410 nm, both values essentially identical to those 
obtained for human lactoferrin and transferrin. The ex- 
tinction coefficient for a 1% solution, however, is 0,30, 
which is approximately half of the corresponding values 
for iron saturated lactoferrin (0.58) [I33 and transferrin 
(0.58) [131. 
The iron titrations (Fig. la) show that the increase in 
absorbance at 464 nm ceases abruptly at a ratio close 
to 1.0 mol of Fe3+ per mol of MTf. This contrast with 
lactofcrrin for which 2.0 mol of Fe3’ are bound per mole 
of protein. 
A similar result is obtained from the measurements 
of fluorescence quenching (Fig. lb). Although the ex- 
tent of fluorescence quenching is not equal for the addi- 
tion of the first and second Fe3+ ion to lactoferrin, at the 
addition of the first, accounting for approximately 70% 
of the observed quenching, the difference between MTP 
and lactoferrin is clearly evident; for MTf no further 
quenching is seen beyond the addition of 1 .O mol of Fe3+ 
per mol of MTf, whereas for lactoferrin quenching is 
not complete until a molar ratio of 2.0 is reached. The 
extent of quenching seen when the single Fe3+ ion is 
Fin. 2. Effect of pH on iron release by melanotransferrin (o), com- 
pared with human lactoferrin (+) and human serum transferrin (0). 
bound by MTf also closely matches that for the binding 
of the first Fe3’ ion to lactoferrin. 
The iron release xperiments how that loss of iron 
from MTf begins at a pH of 6.0 and is complete at pH 
5.0 (Fig. 2). This compares with transferrin, for which 
release occurs over the pH range 6.0-4.0, and lacto- 
ferrin, for which iron release takes place at considerably 
lower pH, beginning at pH 3.5 and complete at pH 2.5. 
4. DTSCUSSlON 
A characteristic property of other members of the 
transferrin family (serum transferrin, ovotransferrin, 
lactoferrin) is the ability to bind reversibly two Fe3+ 
ions, together with two CO:- ions, per molecule. These 
molecules have a strong Z-fold internal amino acid se- 
quence homology which is reflected in their being folded 
into two globular lobes, representing the N-terminal 
and C-terminal halves of the polypeptide chain [7-93. 
Each lobe has a similar 3D structure and a similar bind- 
ing site, wit11 the same groups involved in binding the 
Fe3+ and CO:- ions. 
The present results how clearly that MTf binds only 
one Fe’+ ion per molecule. It is unlikely that this results 
from changes to the overall 3D structure. The high 
sequence identity (-40%) with other transferrins implies 
a very similar structure, as in other homologous 
proteins [14]. The 46% internal sequence identity, higher 
even than in other transferrins, also implies similar fold- 
ing of the N and C-terminal halves. The failure to bind 
a second Fe3+ ion must then result from specific hanges 
within the C-terminal binding site as proposed previ- 
ously [lo]. 
In the N-terminal half of MTf all four of the iron 
ligands found in other transferrins, Asp-60, Tyr-92 and 
His-253 (lactoferrin numbering) are present, as are the 
groups involved in binding the CO:-, Thr-117 and Arg- . . . 
12’1 [S]. This must be the site of iioz bmd;ng in A 111. yw 
The similarity of the absorption spectrum implies that 
the binding site is very like those of other transferrins. 
The pH Jependence of iron release from MTf is also 
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Fig. 3. Stereo views of (a) the C-lobe iron binding site of human lacrofcrrin. showing the iron atom (0). the COj- ion, three of the four iron biading 
residues (Asp-395, Tyr-435 and His-597) and residues of the anion binding site, together with important hydrogen bonds (dashed linu). and (b) 
the equivalent site in melanotransferrin (with the positions of the Fe’* and CO:- ions in lactofcrrin shown for reference). 
similar to that of the ‘acid-labile’ N-terminal site of 
serum transferrin, which loses iron over the pH range 
6.0-5.2 [13] (the tailing-off to lower pH for transferrin 
corresponds to release from its ‘acid-stable’ C-terminal 
site). In all these respects, therefore, the iron-binding 
site in MTI’ resembles a typical serum transferrin-type 
N-terminal site. 
In the C-terminal half of MTf, however, at least four 
specific amino acid changes are found, of residues which 
are totally conserved in other transferrins: 
(i) Asp-395, which binds to iron through one carbox- 
ylate oxygen and hydrogen-bonds across the binding 
cleft to Thr-466 through its other carboxylate oxygen, 
is changed to Ser. Ligation through the Ser hydroxyl 
would be weaker and modelling (Fig. 3) suggests that 
the bond would be longer unless there is some structural 
readjustment. Moreover it could not simultaneously hy- 
drogen-bond across the binding cleft as Asp does; 
(ii) Arg-465, which hydrogen-bonds to the CO!- ion, 
is changed to Ser. Although the Ser hydroxyl could still 
hydrogen-bond to the anion, the charge interaction 
would be lost; 
(iii) Thr-451, -;lrhich hydrogen-bonds to the CO:- ion, 
is changed to Ala, so that this hydrogen bond is lost; (iv) 
Thr-466, which hydrogen-bonds across the binding cleft 
to Asp-395, either through its peptide NH (in lacto- 
ferrin) or its OH (in transferrin) is changed to Pro, so 
this hydrogen bond is also lost. 
None of these changes, shown in Fig. 3, seems uffi- 
cient on its own to abolish binding of Fe3+ and CO:-, but 
taken together they clearly are. Whether the binding site 
is also disrupted by other nearby changes is difficult to 
say, and only an X-ray structure analysis will finally 
answer this question. 
Why does MTf not bind iron in both lobes as other 
transferrins do? The C-terminus is probably involved in 
membrane anchoring [S], although the exact mechanism 
of attachment has not been described. It is also known 
that the potential glycosylation sites and the antigenic 
sites of melanotransferrin are all on the N-terminal half 
[3]. This suggests that the close association of the C-lobe 
with the cell membrane ither limits access of iron or 
prevents the opening of the binding cleft which is neces- 
sary for iron binding [lS]. Alternatively, it is possible 
that only the outer N-lobe is required for whatever i on 
translocation function MTf possesses. Either way, evo- 
lutionary mutations have been able to occur in the C- 
lobe binding cleft in the absence of the selective prcs- 
sures or T*intenal-ce of an iron-binding function, even . . m . .. . . . . . 
though the overall structure is conserved. 
Even in ‘normal’ transferrins the C-terminal site has 
somewhat different properties from the N-terminal site, 
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in that it releases iron less readily, with less facile open- 
ing of the binding clef [15,16]. There have been sugges- 
tions that the two lobes could have different functional 
roles [17], and recent studies of the transferrin receptor 
suggest hat receptor binding is required to ‘pull’ iron 
from the C-terminal site [18]. V!hen taken with our 
results, and the recent report of a more distantly related 
transferrin from the hornworm, Mandtrca sextu, which 
apparently also has a defective C-terminal site, with a 
different pattern of substitutions from MTf [19], it ap- 
pears that the N-lobe has remained fairly constant in its 
properties while the C-lobe has become differentiated 
during evolution since the original gene duplication 
event. 
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